Agregator de Jurnale Medicale de Specialitate

Agregator de Jurnale Medicale de Specialitate

Agregatorul de știri și noutăți prezintă cele mai noi studii clinice și noutăți despre tratamente medicale oncologice, tratamente de radioterapie și radiochirurgie, publicate în jurnalele medicale de specialitate la nivel internatțional:

The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort studyThe added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study, Published online: 16 October 2018; doi:10.1038/s41416-018-0282-8The added [...]
mar, Oct 16, 2018
Source: Jurnalul de Oncologie UK
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursA phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours, Published online: 15 October 2018; doi:10.1038/s41416-018-0281-9A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours [...]
lun, Oct 15, 2018
Source: Jurnalul de Oncologie UK
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerCharacterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer, Published online: 15 October 2018; doi:10.1038/s41416-018-0268-6Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer [...]
lun, Oct 15, 2018
Source: Jurnalul de Oncologie UK
Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancersEpigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers, Published online: 15 October 2018; doi:10.1038/s41416-018-0249-9Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers [...]
lun, Oct 15, 2018
Source: Jurnalul de Oncologie UK
We applaud the Australian and New Zealand Radiation Oncology Genito-Urinary Group for their exemplary review and recommendations of management for prostate cancer patients with recurrence [1]. Technological advances in imaging and radiotherapy have enabled ‘new’ disease states to be recognized and managed, however, these need to be robustly evaluated to [...]
lun, Oct 15, 2018
Source: Jurnalul de Radioterapie & Oncologie